Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Current Assets (2020 - 2025)

Historic Current Assets for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $138.0 million.

  • Treace Medical Concepts' Current Assets fell 1243.96% to $138.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.0 million, marking a year-over-year decrease of 1243.96%. This contributed to the annual value of $161.4 million for FY2024, which is 1863.14% down from last year.
  • Treace Medical Concepts' Current Assets amounted to $138.0 million in Q3 2025, which was down 1243.96% from $147.6 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Current Assets registered a high of $223.1 million during Q1 2023, and its lowest value of $36.5 million during Q1 2021.
  • In the last 5 years, Treace Medical Concepts' Current Assets had a median value of $147.6 million in 2025 and averaged $152.3 million.
  • As far as peak fluctuations go, Treace Medical Concepts' Current Assets skyrocketed by 24925.25% in 2022, and later crashed by 2025.65% in 2025.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Current Assets stood at $138.0 million in 2021, then fell by 3.31% to $133.4 million in 2022, then surged by 48.69% to $198.4 million in 2023, then fell by 18.63% to $161.4 million in 2024, then dropped by 14.5% to $138.0 million in 2025.
  • Its last three reported values are $138.0 million in Q3 2025, $147.6 million for Q2 2025, and $149.4 million during Q1 2025.